PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013 2014 2015 2018
The current blood transfusion system is inadequate to meet the countrys need as the BTU is lacking in capacity and capability. CDC Cameroon intends to buy into an existing HQ cooperative agreement with WHO to seek WHO in-country support in collaboration with the Directorate of Disease Control for ongoing USG support to blood safety services to Cameroon in eight technical areas described below.1. Policy/guideline development update and advocacy effort to seek Global Fund funding for blood safety activities; 2. Infrastructure development for procurement including, waste, maintenance, cold chain and blood bank computer system; 3. Blood collection, screening sustainability materials and protocols for blood processing and distribution; 4. Develop or revise protocols for TTI testing, referral, sero-typing, cross-match, SOPs and policies to ensure good manufacturing practices; 5. Transfusion and blood utilization: 6. Develop M & E tools and plan for monitoring program progress and analyze data on key programmatic indicators; 7. Assess procurement system, blood transfusion service, QA activities; 8. Mentor blood transfusion unit and blood center staff on blood donor management, laboratory procedures, and develop a five-year training plan. WHO will also work in collaboration with USG and other partners to support the development of the National Laboratory Strategic Plan and Policy and also provide advocacy for it's implementation across the tiered health system. WHO will also advocate for and support the creation of a Laboratory Technical Working Group (LTWG) and support and provide TA towards establishment of national laboratory networks, the SLIPTA process and quality assurance systems for HIV, TB and blood safety testing services.
Lab: WHO will work in collaboration with PEPFAR and other partners to support the development of the National Laboratory Strategic Plan and Policy and also provide advocacy for it's implemention accross the tiered health system. WHO will also advocate for and support the creation of a Laboratory Technicl Working Group (LTWG) and support and provide TA towards establishment of national laboratory networks, the SLIPTA process and quality assurance systems for HIV, TB and blood safety testing services.
WHO will support the blood safety program of Cameroon through the following activities: 1. Advocacy: undertake advocacy meetings towards the establishment of a National Blood Transfusion Service (NBTS), restart process or try to move old decree forward by building a case for either an agency or a program for blood safety; Coordination: establish a blood safety Technical Working Group, support for the development of a supervision plan, develop a formal agreement with hospital for quality assurance and establish a testing plan with a goal to have regional and central testing of blood, convene regular supervision meetings; 3. Leadership: lead the blood safety TWG in writing a Global Fund application to support blood safety activities, notably, the establishment of an NBTS or a blood safety program with the Ministry of Public Health. The application will target especially Round 12 of Global Fund funding which is scheduled for June 2013.
